Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPRC | P08575 | 8/20 | 0.62 |
| ▸ | MEN1 | O00255 | 4/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.62 |
| ▸ | NPC1 | O15118 | 4/20 | 0.62 |
| ▸ | RAB9A | P51151 | 4/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.62 |
| ▸ | APAF1 | O14727 | 4/20 | 0.62 |
| ▸ | S100A4 | P26447 | 4/20 | 0.62 |
| ▸ | TDP2 | O95551 | 4/20 | 0.62 |
| ▸ | MAPT | P10636 | 3/20 | 0.62 |
| ▸ | LMNA | P02545 | 3/20 | 0.62 |
| ▸ | HTT | P42858 | 3/20 | 0.62 |
| ▸ | GALK1 | P51570 | 3/20 | 0.62 |
| ▸ | BLM | P54132 | 3/20 | 0.62 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.62 |
| ▸ | PLCG1 | P19174 | 3/20 | 0.62 |
| ▸ | MAOA | P21397 | 2/20 | 0.62 |
| ▸ | THRB | P10828 | 2/20 | 0.62 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.62 |
| ▸ | POLB | P06746 | 2/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyridine SCHEMBL6552256 | 0.84 | TSHR (0.60) | PTPRCMEN1KMT2ANPC1RAB9A | |
| Pyridine SCHEMBL29157767 | 0.84 | TSHR (0.60) | PTPRCMEN1KMT2ANPC1RAB9A | |
| 9,10-Phenanthrenequinone SCHEMBL2157215 | 0.79 | MEN1 (1.00) | PTPRCMEN1KMT2ANPC1RAB9A | |
| 9,10-Phenanthrenequinone SCHEMBL29384320 | 0.79 | MEN1 (1.00) | PTPRCMEN1KMT2ANPC1RAB9A | |
| 9,10-Phenanthrenequinone SCHEMBL31598775 | 0.79 | MEN1 (1.00) | PTPRCMEN1KMT2ANPC1RAB9A | |
| 9,10-Phenanthrenequinone SCHEMBL43050 | 0.79 | MEN1 (1.00) | PTPRCMEN1KMT2ANPC1RAB9A | |
| Phthalic Anhydride SCHEMBL2379597 | 0.76 | TDP1 (0.67) | MEN1KMT2ANPC1RAB9ASMN1; SMN2 | |
| Naphthoquinone SCHEMBL28302474 | 0.76 | CDC25B (0.67) | PTPRCMEN1KMT2ANPC1RAB9A | |
| 9,10-Phenanthrenequinone SCHEMBL29548993 | 0.76 | S100A4 (0.93) | PTPRCMEN1KMT2ANPC1RAB9A | |
| 9,10-Phenanthrenequinone SCHEMBL17536499 | 0.76 | S100A4 (0.93) | PTPRCMEN1KMT2ANPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030082101-A1 | Accelerators for increasing the rate of formation of free radicals and reactive oxygen species | CAVALIER DISCOVERY | 2003-05-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030082101-A1 | Accelerators for increasing the rate of formation of free radicals and reactive oxygen species | SOD1, SOD3, APEX1 | PTPRC 3897/4885MEN1 3202/4885KMT2A 3464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.